Stocknear Logo Stocknear
ctrl K
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
  • Login
    Stocknear Logo Stocknear
    Start new chat
    Home
    Hedge Funds
    Backtesting
    News
    Pricing Plan

    AN2 Therapeutics Inc. (ANTX)

    NASDAQ: ANTX · Real-Time Price · USD
    1.10
    0.05 (4.27%)
    At close: Aug 15, 2025, 3:59 PM
    1.11
    0.78%
    After-hours: Aug 15, 2025, 07:15 PM EDT
      Overview Financials Statistics Metrics Forecast Dark Pool Options Insider Dividends History Profile
      Insider Trading 13F Institute Transcripts

    Transcripts

    Pro Subscription

    Upgrade now for unlimited access to all data, tools and no ads.

    ANTX News

    • 4 days ago - AN2 Therapeutics Commences First-in-Human Clinical Trial of Oral AN2-502998 for Chagas Disease - businesswire.com
    • 24 days ago - AN2 Therapeutics and DNDi Collaborate on Clinical Development of Promising New Oral Compound to Treat Chronic Chagas Disease - businesswire.com
    • 47 days ago - AN2 Therapeutics Reports Key Insights from 200-Patient Observational Study in Acute Melioidosis, Laying Groundwork for Phase 2 Proof-of-Concept Trial of Epetraborole - businesswire.com
    • 79 days ago - AN2 Therapeutics Announces Poster Presentation Highlighting M. Abscessus Data at 2025 Colorado Mycobacteria Conference - businesswire.com

    Add to Watchlist

    logo
    Stocknear

    All-in-one Stock Analysis Platform to research your trading ideas.

    Sections
    • Stocks
    • IPOs
    • ETFs
    • Blog
    Services
    • Pricing Plan
    • Get Support
    • Learning Center
    • Advertise
    Website
    • Login
    • FAQ
    • Sitemap
    Company
    • About
    • Contact Us
    • Terms of Use
    • Privacy Policy
    • Data Disclaimer
    • Imprint
    Youtube-colorCreated with Sketch.

    © 2025 Stocknear. All rights reserved.